$OKYO Pharma (OKYO.US)$ OKYO Pharma Says OK-101 Achieves Sta...

Trytosaveabit commented on a stock · Mar 22 06:05

$OKYO Pharma(OKYO.US)$ OKYO Pharma Says OK-101 Achieves Statistical Significance For Multiple Signs And Symptoms Of Dry Eye Disease Including Ocular Pain Relief In Its First-in-Human Phase 2 Trial Of OK-101

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

1811 Views

Comment

Trytosaveabit

1794Followers

29Following

21KVisitors